highly significantp < 0.0001
The median survival advantage for WBRT + SRS was highly significant ( p < 0.0001) as was the advantage for local tumor control ( p = 0.004) and median time to progression for the treated tumor ( p < 0.00001).
The median survival advantage for WBRT + SRS was highly significant ( p < 0.0001) as was the advantage for local tumor control ( p = 0.004) and median time to progression for the treated tumor ( p < 0.00001).
2.5 months) did not reach statistical significance.
Of these, two showed a trend favoring single-dose SRS + WBRT [ 54 , 56 ] and one a trend favoring resection + WBRT [ 55 ].